Pfizer-BioNTech effective at single dose, longer dose times for Oxford-AstraZeneca, 6 million dose distribution undiagnosed due to winter storms and other COVID-19 vaccine news this week
“There may be benefits in having a 3 month dose interval over a shorter dose interval program for the introduction of a pandemic vaccine to protect as many people in the population as possible as e…
